Walvax Biotechnology Co (SZSE:300142) Ending Cash Position : ¥4,103 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co Ending Cash Position?

Walvax Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥4,103 Mil.

Walvax Biotechnology Co's quarterly Ending Cash Position increased from Sep. 2023 (¥4,073 Mil) to Dec. 2023 (¥4,355 Mil) but then declined from Dec. 2023 (¥4,355 Mil) to Mar. 2024 (¥4,103 Mil).

Walvax Biotechnology Co's annual Ending Cash Position increased from Dec. 2021 (¥3,425 Mil) to Dec. 2022 (¥3,790 Mil) and increased from Dec. 2022 (¥3,790 Mil) to Dec. 2023 (¥4,355 Mil).

Walvax Biotechnology Co Ending Cash Position Historical Data

The historical data trend for Walvax Biotechnology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co Ending Cash Position Chart

Walvax Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

2,362.26

1,960.54

3,424.98

3,790.17

4,354.86

Walvax Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															3,750.46	3,859.46	4,073.22	4,354.86	4,102.79

Walvax Biotechnology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Walvax Biotechnology Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3790.169	+	564.694
	=	4,355

Walvax Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4354.862	+	-252.073
	=	4,103

Walvax Biotechnology Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Walvax Biotechnology Co (SZSE:300142) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Keyuan Road No. 99, 19th Floor, Building 9A, Dingyi Tiancheng Residential Quarter, High & New Tech Development Zone, Yunnan Province, Kunming, CHN, 650106

Website

http://www.walvax.com

Walvax Biotechnology Co Ltd biological pharmaceutical enterprise engaged in research and development, production and sales of bio-medicine products. It offers bio-medicines, such as vaccines, blood products, and others. The company's products include Haemophilus influenza type b conjugate vaccines, freeze-dried group A, C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines, and group A and C meningococcal polysaccharide vaccines.

Executives

Wu Yun Yan	Executives
Zhao Jin Long	Executives
Yao Wei	Executives
Zhou Hua	Executives
Shi Jing	Executives
Jiang Run Sheng	Directors, executives
Gong Sun Qing	Executives
	Executives
Yuan Lin	Executives
Fang Guo Liang	Executives
Li Yun Chun	Director
Huang Zhen	Director
Zhang Li	Secretary Dong
Yang Hong Wei	Supervisors
Xu Ke Ren	Executives

Walvax Biotechnology Co (SZSE:300142) Headlines

No Headlines